Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Growing Recognition of Obesity as a Chronic Disease: Obesity is increasingly being recognized as a chronic and multifactorial disease rather than solely a lifestyle condition
Science backed treatment Ongoing clinical support Trusted by 100k customers across the UK Lower starting doses tested: 1mg weekly: Tested in the phase 2 obesity trials as a fixed dose with no escalation
What was the retatrutide starting dose in the trials
Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Eli J
Theres no one size fits all
:max_bytes(150000):strip_icc()/Simple-7-Day-GLP-1-Friendly-Meal-Plan-for-Beginners-Created-by-a-Dietitian-69f3d02b6c2c41928135df7f0c417552.jpg)
US$ 20.66
US$ 27.40
US$ 21.31
US$ 23.14
US$ 29.89
